Hims & Hers Health, Inc. (HIMS) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US4330001060
Hims & Hers Health, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.35 bn USD |
| Gross profit | 1.73 bn USD |
| Operating income | 105.61 m USD |
| EBIT | 123.92 m USD |
| Net income | 128.37 m USD |
| Diluted EPS – continuing operations | 0.51 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
More stocks
- Hebei Yangyuan ZhiHui Beverage Co Ltd (603156.SS)
- Zhejiang Dahua Technology Co Ltd (002236.SZ)
- Games Workshop Group PLC (GAW.L)
- Yokogawa Electric Corp (6841.T)
- Hitachi Construction Machinery Co Ltd (6305.T)
- STIFEL FINANCIAL CORP (SF)
- Praxis Precision Medicines, Inc. (PRAX)
- Figma, Inc. (FIG)
- Gotion High tech Co Ltd (002074.SZ)
- Alkermes plc. (ALKS)
- Jiujiang Defu Technology Co Ltd Ordinary Shares - Class A (301511.SZ)
- Gigabyte Technology Co Ltd (2376.TW)
Not investment advice. All data without warranty, price as of 19.10.2026. Details in the risk notice.